Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: AbCellera And RQ Bio Partner To Accelerate Advancement Of New Therapies For Infectious Disease

March 22 (Reuters) - Abcellera Biologics Inc  ABCL.O :
    * ABCELLERA AND RQ BIO PARTNER TO ACCELERATE THE ADVANCEMENT
OF
NEW THERAPIES FOR INFECTIOUS DISEASE
    * ABCELLERA BIOLOGICS INC - UNDER AGREEMENT, RQ BIO HAS
RIGHT TO
DEVELOP AND COMMERCIALIZE THERAPEUTIC ANTIBODIES RESULTING FROM
COLLABORATION
    * ABCELLERA BIOLOGICS INC - WILL RECEIVE RESEARCH PAYMENTS
    * ABCELLERA BIOLOGICS INC - IS ELIGIBLE TO RECEIVE
DOWNSTREAM
CLINICAL AND REGULATORY MILESTONE PAYMENTS AND ROYALTIES ON NET
SALES OF PRODUCTS

Source text for Eikon:  ID:nBw7cFQkVa 
Further company coverage:  ABCL.O

Recent news on AbCellera Biologics

See all news